This document discusses, among other things, an apparatus comprising a pump configured to deliver insulin, a processor, and a user interface including a bistable display. A display element of the bistable display is placed in one of two stable orientations upon application of a biasing voltage and stays in the stable orientation when the biasing voltage is removed. The processor includes a display module configured to display a non-blank reversion display screen on the bistable display when no input is received at the user interface after a specified time duration, and to recurrently change the reversion display screen until input is received at the user interface.

This document discusses, among other things, an apparatus comprising a pump configured to deliver insulin, a processor, and a user interface including a bistable display. A display element of the bistable display is placed in one of two stable orientations upon application of a biasing voltage and stays in the stable orientation when the biasing voltage is removed. The processor includes a display module configured to display a non-blank reversion display screen on the bistable display when no input is received at the user interface after a specified time duration, and to recurrently change the reversion display screen until input is received at the user interface.

An ambulatory infusion pump can include a maximum bolus override procedure. When a bolus amount greater than a maximum bolus amount is requested, the pump can provide an alert indicating that the amount requested exceeds the maximum bolus amount. If the user confirms the request in response to the alert, the bolus amount can be delivered to the user. The amount delivered in response to the confirmation can be a first portion of the bolus amount. A reminder can then be provided that a second portion of the bolus amount that is a remaining portion of the requested bolus amount was also requested. If a second confirmation is received in response to the alert, the second portion of the bolus amount can also delivered to the user.

An injection system has: an injection device that injects a drug solution; and a sound detection device that detects sound while a subject is being imaged and generates first data based on the sound, wherein the injection device has a data generation unit that acquires the first data, and a history generation unit that generates injection history data of the drug solution, and the data generation unit generates second data in which the first data is associated with time data in common with the injection history data.

The present disclosure relates to an implantable drug delivery device including a manual control actuator that allows a patient to self-administer a fixed amount of a drug at a desired time. By controlling a drug level, the volume inside a drug chamber, the number of actuations, and the like, a device of the present disclosure allows a drug to be precisely controlled and delivered from the outside after the device is implanted in vivo, and thus it is convenient to control a drug administration schedule. Also, since a battery is not required, and internal control devices for electromagnetic control become unnecessary, it is more patient-friendly and economically feasible.

The present disclosure relates to an implantable drug delivery device including a manual control actuator that allows a patient to self-administer a fixed amount of a drug at a desired time. By controlling a drug level, the volume inside a drug chamber, the number of actuations, and the like, a device of the present disclosure allows a drug to be precisely controlled and delivered from the outside after the device is implanted in vivo, and thus it is convenient to control a drug administration schedule. Also, since a battery is not required, and internal control devices for electromagnetic control become unnecessary, it is more patient-friendly and economically feasible.

Disclosed herein are advantageous drug delivery assemblies, and related methods of fabrication and use thereof. The present disclosure provides improved drug delivery assemblies for extended drug delivery (e.g., via passive diffusion) and/or tunability, and improved systems/methods for utilizing and fabricating the drug delivery assemblies. More particularly, the present disclosure provides single or dual compartment, and dual porous membrane based (e.g., porous zinc membrane based) drug delivery assemblies for extended drug delivery (e.g., via passive diffusion) and/or tunability. The present disclosure also provides for a method for utilizing a drug delivery assembly. The assemblies can be utilized for the extended drug delivery of pharmaceuticals or the like, such as biologics, for the sustained release of medication for greater than six months to overcome difficulties with daily dosing regimes.

Disclosed herein are apparatuses and methods for a user-wearable infusion pump actuated with a shape memory alloy (SMA) wire. Embodiments enable an SMA wire driven infusion pump using a single length of SMA wire to provide multiple pulse sizes and corresponding medicament dispensing sizes. The multiple pulse sizes can include a larger pulse size for larger volumes to limit battery drain but smaller pulse sizes for precision of delivery.

This document discusses, among other things, an apparatus comprising a pump configured to deliver insulin, a processor, and a user interface including a bistable display. A display element of the bistable display is placed in one of two stable orientations upon application of a biasing voltage and stays in the stable orientation when the biasing voltage is removed. The processor includes a display module configured to display a non-blank reversion display screen on the bistable display when no input is received at the user interface after a specified time duration, and to recurrently change the reversion display screen until input is received at the user interface.

A dual lumen IV administration set includes a first lumen having an inner diameter of a first value. A second lumen is paired with the first lumen, and the second lumen has an inner diameter of a second value that is greater than the first value. A flow merger merges flow output from a distal end of the first lumen and flow output from a distal end of the second lumen to form a single flow output in an exit lumen. An injection port intersects the first lumen, thereby providing injection access to flow therethrough, prior to merging with the flow output of the second lumen.